<DOC>
	<DOC>NCT00372307</DOC>
	<brief_summary>Patients with vitiligo vulgaris are treated with Pimecrolimus twice a day during 6 months. After a baseline visit, patient returns for a control visit after 3 and 6 months of treatment. One reference lesion is clinically evaluated with pictures.</brief_summary>
	<brief_title>Efficacy and Safety of Pimecrolimus for the Treatment of Vitiligo Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Vitiligo</mesh_term>
	<mesh_term>Pimecrolimus</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Active or stable vitiligo vulgaris lesions at head or neck + maximum 10% lesions at the rest of the body Topica during last 2 weeks Photo(chemo)therapy during last 4 weeks Segmentary vitiligo</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>